Stoke Therapeutics, Inc.

STOK

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001623526

SEC filings (opens in a new tab)

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Stoke Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of STOK: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	115	1	118	+4
Shares	61.3M	5.41M	58.2M	+2.30M (+4.1%)
Value	$828.5M	$73.1M	$715.5M	−$40.0M (−5.3%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Stoke Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to STOK in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	5,570,150	$68.5M	0.00%
MPM Oncology Impact Management LP	479,452	$5.89M	0.88%
Exome Asset Management LLC	176,600	$2.17M	1.47%
Checkpoint Capital L.P.	157,514	$1.94M	0.96%
Group One Trading, L.P.	101,774	$1.25M	0.05%
Element Capital Management LLC	96,380	$1.18M	0.05%
AQR Capital Management LLC	75,089	$922.8K	0.00%
Prelude Capital Management, LLC	49,900	$613.3K	0.05%
Graham Capital Management, L.P.	17,181	$211.2K	0.01%
Mesirow Financial Investment Management, Inc.	15,604	$191.8K	0.00%
Arrowstreet Capital, Limited Partnership	13,337	$163.9K	0.00%
Intech Investment Management LLC	13,052	$160.4K	0.00%
HRT Financial LP	11,955	$146.0K	0.00%
Citadel Advisors LLC	6,950	$85.4K	0.00%
Acadian Asset Management LLC	1,845	$22.0K	0.00%
Bryn Mawr Trust Co	400	$4.92K	0.00%
True Wealth Design, LLC	139	$1.71K	0.00%
Northwestern Mutual Wealth Management Co	119	$1.46K	0.00%
Jones Financial Companies LLLP	50	$612	0.00%
Sterling Capital Management LLC	37	$455	0.00%
Capital Performance Advisors LLP	32	$393	0.00%
Lindbrook Capital, LLC	30	$369	0.00%
Farther Finance Advisors, LLC	7	$86	0.00%
Bessemer Group Inc	15	$0	0.00%

Sold out (20)

Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of STOK in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Healthcare of Ontario Pension Plan Trust Fund	1,387,200	$18.7M
Logos Global Management LP	1,050,000	$14.2M
Invesco Ltd.	437,136	$5.91M
Sio Capital Management, LLC	175,301	$2.37M
Silverarc Capital Management, LLC	141,518	$1.91M
Walleye Capital LLC	126,830	$1.71M
American Century Companies Inc	59,149	$799.1K
Jacobs Levy Equity Management, Inc	46,059	$622.3K
Verition Fund Management LLC	44,205	$597.2K
Susquehanna Portfolio Strategies, LLC	43,424	$586.7K
Jump Financial, LLC	34,277	$463.1K
EntryPoint Capital, LLC	25,926	$350.3K
Chase Investment Counsel Corp	20,738	$280.0K
Tudor Investment Corp Et Al	18,402	$248.6K
Ghisallo Capital Management LLC	15,000	$202.7K
Renaissance Technologies LLC	11,200	$151.3K
Russell Investments Group, Ltd.	1,527	$20.6K
Pacer Advisors, Inc.	454	$6.13K
SRS Capital Advisors, Inc.	173	$2.34K
Quarry LP	118	$1.59K

Not filed for Q3 2024 yet (1)

Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STOK in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	5,409,169	$73.1M